<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: It has been speculated that zinc finger protein 148 (ZNF148) is a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor </plain></SENT>
<SENT sid="1" pm="."><plain>However, to the authors' knowledge, little is known about the clinical significance of ZNF148 expression in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>The objective of the current study was to clarify the association between ZNF148 expression and the postoperative prognosis of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Tissue microarrays containing 56 <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa, 51 <z:mpath ids='MPATH_270'>adenoma</z:mpath>, 742 CRC (TNM stage I-IV), 16 familial <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">adenomatous polyposis</z:e>, and 21 metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> specimens were examined immunohistochemically for ZNF148 expression </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Expression of ZNF148 was found to increase consecutively from <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa to stage I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and then decreased consecutively from stage I to stage IV <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Lower expression of ZNF148 in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> was found to be significantly associated with <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e>, advanced TNM disease stage, poor differentiation, higher rate of disease recurrence, worse overall survival (OS), and shorter disease-free survival </plain></SENT>
<SENT sid="6" pm="."><plain>High expression of ZNF148 was also associated with improved OS (P = .025) and disease-free survival (P = .042) in patients with stages II to III <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>On multivariate Cox analysis, lower ZNF148 expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, advanced TNM stage, <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, and elevated serum carbohydrate antigen 19-9 (CA19-9) were found to be significant factors for a worse OS </plain></SENT>
<SENT sid="8" pm="."><plain>In 16 patients with <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e>, ZNF148 expression was upregulated at steps toward <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>In 21 patients with metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, although ZNF148 expression was higher in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> compared with adjacent mucosa, its expression in <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic tumors</z:e> was significantly lower than that in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Although ZNF148 expression is related to colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, high ZNF148 expression in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> appears to be inversely associated with malignant phenotypes and may serve as a significant prognostic factor after surgery for patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> 2013;000:000-000. © 2013 American <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Society </plain></SENT>
</text></document>